Selected price target: $30, approximately 34.5% above the $22.30 close on August 12, 2026, and not yet reached. Strongest bullish factors: accelerating annual recurring revenue (ARR), record net-new ARR growth, an AI-native platform, and improving losses.

UiPath (PATH) is scheduled to report second quarter fiscal 2027 results after the market closes on Thursday, September 3, 2026. Wall Street consensus projects adjusted (non-GAAP) earnings per share (EPS) of about $0.15, roughly flat with $0.15 in the year-ago quarter.

Selected price target: $38 per share, roughly 87% above the August 12, 2026 close near $20.35. Bullish factors: an 11.5-gigawatt development pipeline, blue-chip partners, proprietary TRISO-X fuel technology, and a Buy-leaning analyst consensus with a $37.86 average target.

SailPoint, Inc. ( SAIL ) closed at $18.73 on August 12, 2026, meaning a move to $25 would require roughly 33% upside. The $25 stock price target is the most bullish published 12-month analyst objective and sits just above the stock's 52-week high of $24.00.

Maase Inc. ( MAAS ) is a NASDAQ-listed common stock, not an exchange-traded fund (ETF); it closed at $16.42 in the latest regular session, with after-hours trading near $16.58. The selected $30 stock price target sits roughly 83% above the latest close and would require a decisive breakout beyond the 52-week high of $24.90.

Selected target: $20 per share, roughly 44% above Avantor's recent price near $13.93 and above the highest current Street target of $19. Strongest bullish factors: a second-quarter earnings beat, raised fiscal 2026 adjusted EPS guidance, cost-savings turnaround efforts, a $500 million buyback authorization, and expansion in high-purity silicone applications.

The selected stock price target is $24 , about 34% above BMNR's recent close near $17.89. $24 sits just below the lowest current Wall Street 12-month analyst target of $25 and near a widely discussed $23–$24 resistance zone.

Blue Owl Capital shares rose approximately 31.5% in the 30 days through August 12, 2026, climbing from a July 13 close of $9.29 to a latest available price of $12.22. Second-quarter 2026 results, released July 30, showed distributable earnings per share of $0.22 in line with consensus and fee-related revenue above estimates, fueling a 6.4% single-session gain.

EQX shares rose roughly 22% over the 30-day stretch from mid-July to mid-August 2026, moving from a July 13, 2026 close of $9.45 to about $11.55 in the latest available session. The advance coincided with a sharp rebound in gold, which posted its largest one-day gain since February on August 5, 2026, and extended above $4,300 per ounce.

CHYM rose about 50.8% over the past 30 days, from a closing price of $20.95 on July 13, 2026, to $31.60 on August 12, 2026. The advance was driven primarily by Chime's second-quarter 2026 earnings beat, a second consecutive GAAP profit, and raised full-year revenue guidance.

JHX shares rose roughly 27% over the 30 days through mid-August, from a July 13 closing level near $24.29 to about $30.86. The advance accelerated after James Hardie reported stronger-than-expected fiscal first-quarter 2027 results and raised its full-year sales and adjusted EBITDA guidance.

SMCI climbed roughly 36% in the last 30 days, rising from a closing price of $27.65 on July 14, 2026, to $37.61 on August 12, 2026. The rally was powered by a July 21 preliminary update disclosing more than $60 billion in fiscal-fourth-quarter new orders and a record backlog.

Selected price target: $60 per share, a psychological and technical level just above the August record high of $58.94. Strongest bullish factors: a proven acquisition-and-transformation model, Mizuho's raised $72.28 price target, and rapid revenue growth.

Unity Software shares rose about 40% over the last 30 days, from a July 14 close of $31.75 to $44.54 at the latest available quote. The main catalyst was Q2 2026 earnings on Aug. 6: revenue of $546 million beat consensus, while adjusted EBITDA reached $160 million.

Coeur Mining shares climbed roughly 17.5% over the trailing 30 days, from a closing price of $16.00 on July 14, 2026, to a latest available intraday price near $18.80. The advance was closely tied to a sharp rebound in silver, which recovered from about $56 per ounce in early August toward the $64–$66 range on safe-haven demand, a softer U.S. dollar, and lower Treasury yields.

Selected price target: $20 per share, roughly 54% above recent trading levels near $13. Strongest bullish factor: DURAVYU, the company's lead sustained-delivery eye treatment, is advancing through pivotal Phase 3 trials, with wet AMD data anticipated beginning in August 2026.

Selected stock price target: $40, which sits just above LEGN’s 52-week high of $38.35 and implies nearly double the recent price near $20.60. Strongest bullish factors: accelerating Carvykti sales, the first quarter of company-wide profitability, and promising early in vivo CAR-T data.

GFUZ is trading down -9.03% during Wednesday's regular session at $8.36, versus the prior close of $9.19. The decline follows Tuesday's +5.39% gain, putting shares in a sharp pullback amid continued post-SPAC volatility.

TOP Financial Group shares are down -8.55% during regular market hours on Aug. 12, slipping to $11.02 from the prior close of $12.05. The pullback follows a sharp post-consolidation rally after the company's 1-for-5 share consolidation took effect on Aug. 3.

WeRide shares are down -9.32% during regular U.S. trading, last near $5.74 after closing at $6.33 on Tuesday. The drop follows Q2 2026 results released before the open: revenue jumped +92% y/y to $34.15 million, but continued losses weighed on sentiment.